US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: Exploring a Potential 38.93% Upside in the Healthcare Innovator

ResMed Inc. (NYSE: RMD), a prominent player in the Healthcare sector, is capturing the attention of investors with its promising financials and a significant potential upside. Specializing in the Medical..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 16.52% Upside Potential with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $21.83 billion, this Burlington,..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 12.22% Potential Upside

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company is..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring the 22% Upside Potential

For investors seeking growth opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing proposition. With a market capitalization of $29.65 billion, GE HealthCare is a..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 13% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices industry, presents an intriguing opportunity for investors keen on the healthcare sector. With its focus on continuous glucose monitoring..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Opportunities with a $32.19 Billion Market Cap

Centene Corporation (NYSE: CNC), a formidable player in the healthcare plans industry, commands a market capitalization of $32.19 billion. This positions the company as a significant entity in the U.S...

STERIS plc (STE) Investor Outlook: Exploring a 23.75% Potential Upside in the Medical Devices Sector

Investors eyeing the healthcare sector’s robust growth potential may find STERIS plc (STE) an intriguing prospect. With a market cap of $20.23 billion, STERIS plc stands out in the medical..

Veeva Systems Inc. (VEEV) Investor Outlook: Analyzing Growth Potential with a 53.87% Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare sector, particularly within the health information services industry. With a market capitalization of $25.92 billion, this Pleasanton,..

Novartis AG (NVS) Stock Analysis: Balancing High Dividend Yield with Modest Growth Prospects

As a titan in the healthcare sector, Novartis AG (NYSE: NVS) continues to capture the attention of investors with its robust market presence and a market cap of $292.07 billion...

BeOne Medicines Ltd. (ONC) Stock Analysis: A Potential 55.91% Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, has captured investor attention with a compelling potential upside of 55.91%, according to analyst consensus. Headquartered in Basel, Switzerland,..

argenx SE (ARGX) Stock Analysis: Exploring a 15.47% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a Netherlands-based biotechnology company, stands as a compelling player in the healthcare sector, boasting a market cap of $55.84 billion. Specializing in developing therapies for autoimmune..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 11.34% Potential Upside Amid Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a leader in the healthcare sector, continues to capture investor attention with its robust portfolio and promising financial outlook. Headquartered in North Chicago, Illinois, AbbVie focuses..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 31.52% Potential Upside in the Healthcare Market

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling opportunity for investors seeking exposure to the burgeoning..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 10.41% Upside in the Healthcare Giant

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products. With a market capitalization of $116.66 billion,..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 32% Potential Upside with Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a cornerstone for investors seeking a blend of stability and growth. With a market capitalization of $153.59..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 56.58% Upside Potential in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic industries, is drawing investor attention with its strong market position and..

Edwards Lifesciences (EW) Stock Analysis: Strong Buy Ratings Point to a 13.88% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry with a robust portfolio of cardiovascular products, remains a compelling choice for investors seeking growth in the healthcare..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Ratings and Nearly 9% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is drawing attention from investors with a compelling combination of robust growth metrics and a solid analyst consensus...

GSK plc (GSK) Stock Analysis: Unveiling a 6.77% Potential Upside Amid Robust Healthcare Portfolio

GSK plc (GSK) stands as a formidable entity within the healthcare sector, operating under the Drug Manufacturers – General industry. With a rich history dating back to 1715, GSK has..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds